Laumart (Omeprazole)

Omeprazole blocks the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. This irreversible inhibition stops the final step of acid production, leading to a sustained increase in gastric pH and relief from acid‑mediated damage.

The appropriate dose of Laumart is determined by the prescribing healthcare professional based on the specific indication, patient age, renal function and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for omeprazole in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To order Laumart, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Laumart (omeprazole) is a first‑generation proton pump inhibitor with a well‑established efficacy and safety profile. Compared with newer agents such as esomeprazole or pantoprazole, omeprazole offers similar acid suppression but may have a slightly different interaction profile, especially with drugs metabolised by CYP2C19.

Store Laumart at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Laumart is taken orally, usually as a whole tablet swallowed with a glass of water. It is generally recommended to take the dose before a meal, but patients should follow the specific instructions provided by their prescriber.

Serious risks, although rare, include Clostridioides difficile infection, severe allergic reactions such as anaphylaxis, liver enzyme elevations, hypomagnesemia with long‑term use, increased risk of bone fractures, and interstitial nephritis. Patients should seek medical attention if they experience any of these symptoms.

Laumart should be avoided in individuals with known hypersensitivity to omeprazole or any component of the formulation. Caution is also advised for patients with severe liver disease, those taking certain interacting medications, and patients with a history of fracture risk when used long‑term.